Waystar Appoints Aashima Gupta and Michael Roman to Board of Directors

Waystar Holding Corp (Nasdaq: WAY), a healthcare payment software provider, has appointed two distinguished leaders to its Board of Directors.

Rhea-AI Summary

Waystar Holding Corp (Nasdaq: WAY), a healthcare payment software provider, has appointed two distinguished leaders to its Board of Directors. Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, brings expertise in AI strategy and digital healthcare transformation. She currently serves on multiple boards including Neogen and was named among Modern Healthcare's Top 10 Executives to Watch in 2024. Michael Roman, former Executive Chairman and CEO of 3M, joins with nearly 40 years of experience leading a $32 billion global technology company. Roman, who currently serves on Abbott Laboratories' board, brings strategic leadership and operational excellence, particularly notable given 3M's significant healthcare division which represents 25% of its revenue.

Positive

• Addition of Google Cloud's healthcare strategy leader brings valuable AI and digital transformation expertise
• Appointment of former 3M CEO adds significant operational and healthcare industry experience
• New directors bring complementary expertise in technology innovation and enterprise leadership
• Both directors have strong healthcare industry connections and board experience with major companies

Negative

• None.

Argus Session date unavailable

-1.06% session move Open Argus

Details

News Market Reaction – WAY

The recorded move for WAY in the trading session of this news was -1.06%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New directors bring deep expertise in AI innovation, healthcare, and enterprise growth

LEHI, Utah and LOUISVILLE, Ky., June 16, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the appointment of two accomplished leaders, Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, and Michael Roman, former Executive Chairman of the Board and Chief Executive Officer of 3M, to its Board of Directors.

"We're honored to welcome Aashima and Mike to Waystar's Board," said Matt Hawkins, Chief Executive Officer at Waystar. "They bring distinguished experience and expertise at the intersection of innovation, healthcare, and enterprise leadership. Their perspectives and strategic acumen will help guide our continued growth and innovation as we advance our mission to simplify healthcare payments and continue delivering long-term value to our clients, shareholders, and team members."

Ms. Gupta brings significant expertise in AI strategy and digital transformation to improve healthcare access and efficiency. At Google Cloud, she has spearheaded groundbreaking healthcare AI initiatives, leveraging cloud and data technologies to improve care access, efficiency, and outcomes at scale. She also serves on the boards of Neogen, Mölnlycke Health Care, and the HIMSS Global Health Advisory Board. Modern Healthcare named Ms. Gupta one of the Top 10 Executives to Watch in 2024.

Mr. Roman served at 3M for nearly 40 years, including as CEO, chairman, and executive chairman. He is recognized for his strategic leadership, operational excellence, and product innovation at a global technology company generating approximately $32 billion in annual revenue, a quarter of which came from its healthcare division. Mr. Roman currently serves on the board of Abbott Laboratories and the Board of Trustees for the University of Minnesota Foundation.

About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Media Contact
Kristin Lee
kristin.lee@waystar.com

Investor Contact
Sandy Draper
investors@waystar.com
502-238-9511

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-appoints-aashima-gupta-and-michael-roman-to-board-of-directors-302482680.html

SOURCE Waystar

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who are the new board members appointed to Waystar (WAY)?

Waystar appointed Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, and Michael Roman, former Executive Chairman and CEO of 3M, to its Board of Directors.

What experience does Aashima Gupta bring to Waystar's board?

Aashima Gupta brings expertise in AI strategy and digital transformation in healthcare from her role at Google Cloud, and serves on boards of Neogen, Mölnlycke Health Care, and HIMSS Global Health Advisory Board.

What is Michael Roman's background before joining Waystar's board?

Michael Roman served at 3M for nearly 40 years, including roles as CEO, chairman, and executive chairman, leading a $32 billion global technology company with significant healthcare operations.

How will these appointments benefit Waystar (WAY)?

The appointments bring strategic expertise in AI innovation, healthcare technology, and enterprise leadership to help guide Waystar's growth and advance its healthcare payments mission.

What other board positions do Waystar's new directors currently hold?

Aashima Gupta serves on boards of Neogen, Mölnlycke Health Care, and HIMSS Global Health Advisory Board, while Michael Roman serves on Abbott Laboratories' board and the University of Minnesota Foundation Board of Trustees.